Buprenorphine-Naloxone Use in ER & Other Acute Care Settings

Buprenorphine-Naloxone Use in ER & Other Acute Care Settings

Buprenorphine-Naloxone Use in the ER and Other Acute Care Settings:  Common Clinical Scenarios

 

Accredited for 1.0 AMA PRA Category 1 Credits

 

Thurs., Sept. 14, 2023

Noon – 1 p.m. ET

 

 



 

Fee:

 

The 2023 Live Opioid CME Series is FREE for members and nonmembers,

thanks to support by a State Opioid Response Grant from:



Indiana Family and Social Services Administration
Division of Mental Health and Addiction

Registration required.


Program description:

This webinar is intended to support providers interested in using Buprenorphine-Naloxone in the ER/hospital and other acute care settings.  Krista Brucker, MD, emergency and addiction medicine specialist, will review the common forms of treatment for Opioid Use Disorder (OUD) during this live discussion, Focuses will include how to help patients move from active drug use to Buprenorphine and how to take care of patients who are maintained on Buprenorphine. In addition to discussing routine cases, Dr. Brucker will also  talk about several of the more common clinical complexities that arise, including patients using fentanyl, those who are pregnant, have acute pain, liver disease and use of sedative co-prescribing.

Objectives:

At the end of this webinar, attendees will be able to:

  • Identify the three FDA-approved medications for Opioid Use Disorder (OUD)
  • Comprehend precipitated withdrawal so that they feel confident in starting patients on buprenorphine, both in the ER/hospital and at home
  • Manage common clinical challenges that arise for patients on buprenorphine-naloxone (i.e. pregnancy, acute pain and chronic liver disease).  


Speaker:

 

Krista Brucker, MD
Emergency and Addiction Medicine Specialist


A
bout our speaker:

Dr. Brucker completed her emergency medicine residency at Northwestern University’s Feinberg School of Medicine in Chicago. She is board certified in both emergency and addiction medicine and is a graduate of Harvard Medical School. Dr. Brucker is a Minnesota native and earned her undergraduate degree in biochemistry from DePauw University in Greencastle, Indiana.

Dr. Brucker has an addiction medicine practice at Oaklawn South Bend that provides a full range of mental health and addiction services. She is also a partner with South Bend Emergency Physicians, which provides emergency room services for Memorial Hospital South Bend.

Dr. Brucker’s interest in addiction medicine grew out of her time as a junior faculty member at Indiana University School of Medicine’s Department of Emergency Medicine. There, she designed and implemented Project POINT, a collaborative effort aimed at identifying, treating, and linking patients with opioid use disorders to life-saving medications and post discharge treatment.  

Since moving to South Bend in 2019, Dr. Brucker has supported expanded access to medications for OUD both within Beacon Health System and through her work in the addiction medicine program at Oaklawn South Bend, as well as with the county's opioid response team.


CME information:

Designation Statement: The Indiana State Medical Association (ISMA) designates this live webinar for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Accreditation Statement
: The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Disclosure Policy: In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity, and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any financial relationships with an “ineligible company” whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Statement: No member of the CME Planning Committee or our speaker have any relevant financial relationships with an ineligible company to disclose.

 

If you have questions, contact ISMA Continuing Medical Education staff at 800-257-4762 or seminars@ismanet.org.


REGISTRATION DEADLINE: Sept. 14, 2023, at 11:30 a.m. ET

REGISTRATION DETAILS

When registering, please ensure you are taking the following steps to complete the order.

  1. Click on the “Register” button at the bottom of the event landing page.
  2. Your registration will then be “pending checkout.”  Please click on the “Proceed to Checkout” button.
  3. Your Shopping Cart will display.  Please click on the “Submit Order” button.
  4. Once you’ve successfully submitted the order, an Order Confirmation page pops up indicating that “a confirmation email is being sent to you” at the email address on file.  That confirmation email will contain the Zoom link needed to access the webinar. 


Please be sure to add ismanet.org to your White List (Safe Senders List).  This will ensure you receive our registration confirmation emails, as well as your CME certificates post-conference.

What is a whitelist sender?

An email whitelist is an approved list of senders you and your readers clearly define to ensure your email service provider (ESP) doesn't block and/or mark the content as spam.  You can add your contacts and other correspondents to the Safe Senders list to confirm you'll always receive their messages in your inbox.

 

 
When
9/14/2023 12:00 PM - 1:00 PM
Where
Live Webinar IN UNITED STATES
Online registration not available.